Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia

Leuel Lisanwork Arage,1 Haji Aman Deybasso,2 Delelegn Yilma Gebremichael,3 Binyam Gintamo Nuramo,4 Zelalem Negash Mekuria4 1The Ohio State University Global One Health, Addis Ababa, Ethiopia; 2Adama Hospital Medical College, Adama, Ethiopia; 3Ambo University, College of Medicine and Health Sciences,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lisanwork Arage L, Deybasso HA, Yilma Gebremichael D, Gintamo Nuramo B, Negash Mekuria Z
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	isoniazid and rifapentine tpt hepatotoxicity hiv patients ethiopia Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/7b31f9fc17c041ea8d0b5fbc9cb8f96c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7b31f9fc17c041ea8d0b5fbc9cb8f96c
record_format	dspace
spelling	oai:doaj.org-article:7b31f9fc17c041ea8d0b5fbc9cb8f96c2021-12-02T18:21:01ZDeterminants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia1179-1373https://doaj.org/article/7b31f9fc17c041ea8d0b5fbc9cb8f96c2021-03-01T00:00:00Zhttps://www.dovepress.com/determinants-of-drug-induced-hepatotoxicity-among-patients-with-human--peer-reviewed-article-HIVhttps://doaj.org/toc/1179-1373Leuel Lisanwork Arage,1 Haji Aman Deybasso,2 Delelegn Yilma Gebremichael,3 Binyam Gintamo Nuramo,4 Zelalem Negash Mekuria4 1The Ohio State University Global One Health, Addis Ababa, Ethiopia; 2Adama Hospital Medical College, Adama, Ethiopia; 3Ambo University, College of Medicine and Health Sciences, Department of Public Health, Ambo, Ethiopia; 4Addis Ababa Medical and Business College, Department of Research and Community Service, Addis Ababa, EthiopiaCorrespondence: Haji Aman Deybasso Tel +251 911386781Email hajia.aman9@gmail.comPurpose: The drugs for the treatment of latent Tuberculosis are potentially hepatotoxic and can lead to drug-induced hepatotoxicity. The current study aimed at identifying the determinants of anti-tuberculosis drug-induced hepatotoxicity among patients living with Human Immunodeficiency Virus taking Isoniazid and rifapentine at All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia.Methods: An unmatched case–control study was conducted from March, 21, to April 21, 2020, at All Africa Leprosy Tuberculosis Rehabilitation and Training Center. A total of 65 cases and 130 controls were interviewed. Data were collected using a data extraction tool from clinical reporting forms, follow-up charts, and patients’ logbooks. Binary and multiple logistic regressions were conducted to check the association between independent and dependent variables. Adjusted odds ratios and the corresponding 95% confidence intervals were estimated to assess the strength of association. P-values < 0.05 were used to declare statistical significance.Results: The prevalence of anti-TB drug-induced hepatotoxicity was 8%. Body mass index < 18.5 Kg/m2 (AOR = 5.8 [95% CI: 2.2– 8.9]), low CD4 count (AOR = 4.9 [95% CI: 1.6– 15.8]), and the presence of comorbid illnesses (AOR = 3.9 [95% CI: 1.7– 8.9]) were identified as independent predictors of drugs-induced hepatotoxicity among Human Immunodeficiency Virus positive patients taking Isoniazid and rifapentine.Conclusion: The prevalence of anti-TB drug-induced hepatotoxicity was higher compared to standard references. BMI< 18 kg/m2, low CD4 count, and comorbid illness were positively associated with anti-tuberculosis drug-induced hepatotoxicity among patients with HIV.Keywords: isoniazid and rifapentine, TPT, hepatotoxicity, HIV patients, EthiopiaLisanwork Arage LDeybasso HAYilma Gebremichael DGintamo Nuramo BNegash Mekuria ZDove Medical Pressarticleisoniazid and rifapentinetpthepatotoxicityhiv patientsethiopiaImmunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol Volume 13, Pp 307-314 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	isoniazid and rifapentine tpt hepatotoxicity hiv patients ethiopia Immunologic diseases. Allergy RC581-607
spellingShingle	isoniazid and rifapentine tpt hepatotoxicity hiv patients ethiopia Immunologic diseases. Allergy RC581-607 Lisanwork Arage L Deybasso HA Yilma Gebremichael D Gintamo Nuramo B Negash Mekuria Z Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia
description	Leuel Lisanwork Arage,1 Haji Aman Deybasso,2 Delelegn Yilma Gebremichael,3 Binyam Gintamo Nuramo,4 Zelalem Negash Mekuria4 1The Ohio State University Global One Health, Addis Ababa, Ethiopia; 2Adama Hospital Medical College, Adama, Ethiopia; 3Ambo University, College of Medicine and Health Sciences, Department of Public Health, Ambo, Ethiopia; 4Addis Ababa Medical and Business College, Department of Research and Community Service, Addis Ababa, EthiopiaCorrespondence: Haji Aman Deybasso Tel +251 911386781Email hajia.aman9@gmail.comPurpose: The drugs for the treatment of latent Tuberculosis are potentially hepatotoxic and can lead to drug-induced hepatotoxicity. The current study aimed at identifying the determinants of anti-tuberculosis drug-induced hepatotoxicity among patients living with Human Immunodeficiency Virus taking Isoniazid and rifapentine at All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia.Methods: An unmatched case–control study was conducted from March, 21, to April 21, 2020, at All Africa Leprosy Tuberculosis Rehabilitation and Training Center. A total of 65 cases and 130 controls were interviewed. Data were collected using a data extraction tool from clinical reporting forms, follow-up charts, and patients’ logbooks. Binary and multiple logistic regressions were conducted to check the association between independent and dependent variables. Adjusted odds ratios and the corresponding 95% confidence intervals were estimated to assess the strength of association. P-values < 0.05 were used to declare statistical significance.Results: The prevalence of anti-TB drug-induced hepatotoxicity was 8%. Body mass index < 18.5 Kg/m2 (AOR = 5.8 [95% CI: 2.2– 8.9]), low CD4 count (AOR = 4.9 [95% CI: 1.6– 15.8]), and the presence of comorbid illnesses (AOR = 3.9 [95% CI: 1.7– 8.9]) were identified as independent predictors of drugs-induced hepatotoxicity among Human Immunodeficiency Virus positive patients taking Isoniazid and rifapentine.Conclusion: The prevalence of anti-TB drug-induced hepatotoxicity was higher compared to standard references. BMI< 18 kg/m2, low CD4 count, and comorbid illness were positively associated with anti-tuberculosis drug-induced hepatotoxicity among patients with HIV.Keywords: isoniazid and rifapentine, TPT, hepatotoxicity, HIV patients, Ethiopia
format	article
author	Lisanwork Arage L Deybasso HA Yilma Gebremichael D Gintamo Nuramo B Negash Mekuria Z
author_facet	Lisanwork Arage L Deybasso HA Yilma Gebremichael D Gintamo Nuramo B Negash Mekuria Z
author_sort	Lisanwork Arage L
title	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia
title_short	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia
title_full	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia
title_fullStr	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia
title_full_unstemmed	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia
title_sort	determinants of drug-induced hepatotoxicity among patients with human immunodeficiency virus taking a high dose of rifapentine plus isoniazid drugs at the all africa leprosy tuberculosis rehabilitation and training center in addis ababa, ethiopia
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/7b31f9fc17c041ea8d0b5fbc9cb8f96c
work_keys_str_mv	AT lisanworkaragel determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopia AT deybassoha determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopia AT yilmagebremichaeld determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopia AT gintamonuramob determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopia AT negashmekuriaz determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopia
_version_	1718378163467190272

Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia

Ejemplares similares